MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma

• Alireza Torabi,
• Jonathan R Fromm,
• Kikkeri N Naresh

Affiliations

Alireza Torabi

Department of Laboratory Medicine and Pathology Division of Hematopathology University of Washington Seattle Washington USA

Jonathan R Fromm

Department of Laboratory Medicine and Pathology Division of Hematopathology University of Washington Seattle Washington USA

Kikkeri N Naresh

Pathology Program Translational Science and Therapeutics Division Fred Hutchinson Cancer Research Center Seattle Washington USA